Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sanduloviciu, Maria"'
Autor:
Sanduloviciu, Maria1, Stoll, Delphine1, Lamy, Olivier1, Krieg, Marc-Antoine2, Aubry-Rozier, Bérengère1 Berengere.aubry@chuv.ch
Publikováno v:
Praxis (16618157). 8/6/2014, Vol. 103 Issue 16, p939-944. 6p.
Publikováno v:
Revue médicale suisse, Vol. 11, No 477 (2015) pp. 1222-1226
Metformin is the first-line oral agent for the treatment of type 2 diabetes according to the guidelines. Metformin decreases hepatic glucose production, does not induce weight gain and does not increase the risk of hypoglycemia. However, decades afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::0ab42e98face438dd0fafa11266ceb0c
https://archive-ouverte.unige.ch/unige:96964
https://archive-ouverte.unige.ch/unige:96964
Autor:
Sanduloviciu M, Jornayvaz FR
Publikováno v:
Revue medicale suisse [Rev Med Suisse] 2015 Jun 03; Vol. 11 (477), pp. 1222-6.
Autor:
Sanduloviciu M; Centre des maladies osseuses, Lausanne University Hospital., Stoll D; Centre des maladies osseuses, Lausanne University Hospital., Lamy O; Centre des maladies osseuses, Lausanne University Hospital., Krieg MA; Service de rhumatologie, Hôpitaux Fribourgeois., Aubry-Rozier B; Centre des maladies osseuses, Lausanne University Hospital.
Publikováno v:
Praxis [Praxis (Bern 1994)] 2014 Aug 06; Vol. 103 (16), pp. 939-44.